中国抗癌协会神经内分泌肿瘤诊治指南(2022年版)  

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm(2022 edition)

作　　者：中国抗癌协会神经内分泌肿瘤专业委员会 陈洁[2,3] 聂勇战 吴文铭[5] Society of Neuroendocrine Neoplasm of China Anti-Cancer Association;CHEN Jie;NIE Yongzhan;WU Wenming

机构地区：[1]不详 [2]复旦大学附属肿瘤医院神经内分泌肿瘤中心 [3]复旦大学附属肿瘤医院头颈及神经内分泌肿瘤内科 [4]空军军医大学西京医院消化内科 [5]北京协和医院基本外科

出　　处：《中国癌症杂志》2022年第6期545-580,共36页China Oncology

摘　　要：神经内分泌肿瘤(neuroendocrine neoplasm,NEN)是一类起源于肽能神经元和神经内分泌细胞,具有神经内分泌分化并表达神经内分泌标志物的少见肿瘤,可发生于全身各处,以肺及胃肠胰NEN(gastroenteropancreatic neuroendocrine neoplasm,GEP-NEN)最常见。国内外研究数据均提示,NEN的发病率在不断上升。美国流行病学调查结果显示,与其他类型肿瘤相比,NEN的发病率上升趋势更为显著。中国抗癌协会神经内分泌肿瘤专委会在现有循证医学证据基础上,结合已有国内外指南和共识,制订了首版中国抗癌协会神经内分泌肿瘤诊治指南,为临床工作者提供参考。Neuroendocrine neoplasm(NEN)is a kind of rare tumor that originated from peptidergic neurons and neuroendocrine cells,which has neuroendocrine differentiation and expresses neuroendocrine markers.NEN occurs in all parts of the body,especially in lung,stomach,intestine and pancreas.Domestic and international research data suggested that the incidences of NEN were rising.The results of epidemiological investigation showed that compared with other types of tumors,the incidences of NEN increased more significantly.On the basis of existing evidence,combined with domestic and international guidelines and consensus,the Society of Neuroendocrine Neoplasm of China Anti-Cancer Association has formulated its first guideline for diagnosis and treatment of NEN as reference for clinical physicians.

关 键 词：神经内分泌肿瘤 诊断 治疗 指南 

分 类 号：R73[医药卫生—肿瘤]